[EN] COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY<br/>[FR] COMPOSITIONS ET PROCÉDÉS DE MODULATION DE L'ACTIVITÉ DE LA DÉSHYDROGÉNASE À CHAÎNE COURTE
申请人:UNIV CASE WESTERN RESERVE
公开号:WO2015065716A1
公开(公告)日:2015-05-07
Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors described herein.
[EN] INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS<br/>[FR] INHIBITEURS DE L'ACTIVITÉ DE LA DÉSHYDROGÉNASE À CHAÎNE COURTE POUR LE TRAITEMENT DE LA FIBROSE
申请人:UNIV CASE WESTERN RESERVE
公开号:WO2016144958A1
公开(公告)日:2016-09-15
A method of treating or preventing a fibrotic disease, disorder or condition includes administering to a subject in need of treatment a 15-PGDH inhibitor.
治疗或预防纤维化疾病、紊乱或状况的方法包括向需要治疗的对象施用15-PGDH抑制剂。
[EN] INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH<br/>[FR] INHIBITEURS DE L'ACTIVITÉ DÉSHYDROGÉNASE À CHAÎNE COURTE POUR FAVORISER LA NEUROGENÈSE ET INHIBER LA MORT DES CELLULES NERVEUSES
申请人:UNIV CASE WESTERN RESERVE
公开号:WO2018017582A1
公开(公告)日:2018-01-25
A method of promoting neuroprotection in a subject from axonal degeneration, neuronal cell death, and/or glia cell damage after injury, augmenting neuronal signaling underlying learning and memory, stimulating neuronal regeneration after injury, and/or treating a disease, disorder, and/or condition of the nervous system in a subject in need thereof includes administering to the subject a therapeutically effective amount of a 15-PGDH inhibitor.
chemo-selective electrochemical oxidation of thioethers to sulfoxides and sulfones was developed. The hydrogenbonding network generated from hexafluoro-2-propanol (HFIP) and acetic acid (AcOH) plays an important role in the modulation of oxidationpotential. The hydrogenbonding network complexes strongly with the sulfoxide, making it less prone to further oxidation. Therefore, thioethers can be selectively
Inhibitors of 15-Prostaglandin Dehydrogenase To Potentiate Tissue Repair
作者:Monika I. Antczak、Yongyou Zhang、Changguang Wang、Jennifer Doran、Jacinth Naidoo、Sukesh Voruganti、Noelle S. Williams、Sanford D. Markowitz、Joseph M. Ready
DOI:10.1021/acs.jmedchem.7b00271
日期:2017.5.11
The enzyme 15-prostaglandin dehydrogenase (15-PGDH) catalyzes the first step in the degradation of prostaglandins including PGE2. It is a negative regulator of tissue repair and regeneration in multiple organs. Accordingly, inhibitors of 15-PGDH are anticipated to elevate in vivo levels of PGE2 and to promote healing and tissue regeneration. The small molecule SW033291 (1) inhibits 15-PGDH with K-i = 0.1 nM in vitro, doubles PGE2 levels in vivo, and shows efficacy in mouse models of recovery from bone marrow transplantation, ulcerative colitis, and partial hepatectomy. Here we describe optimized variants of 1 with improved solubility, druglike properties, and in vivo activity.